about
Autoantigen Microarray for High-throughput Autoantibody Profiling in Systemic Lupus ErythematosusPreclinical lupusPrevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.Mining and Environmental Health Disparities in Native American Communities.Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based studyIncreased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema.Lupus-like oral mucosal lesions in mercury-induced autoimmune response in Brown Norway ratsDiscovery of biomarkers for systemic lupus erythematosus using a library of synthetic autoantigen surrogates.Frequency of antinuclear antibody positivity in patients with pattern hair loss.Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis.Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics.Increased risk of systemic lupus erythematosus in 29,000 patients with biopsy-verified celiac disease.IgG and IgM autoantibody differences in discoid and systemic lupus patients.Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.Autoantibody profiling to follow evolution of lupus syndromesAssociations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis controls.Excess female siblings and male fetal loss in families with systemic lupus erythematosus.From pathogenesis, epidemiology, and genetics to definitions, diagnosis, and treatments of cutaneous lupus erythematosus and dermatomyositis: a report from the 3rd International Conference on Cutaneous Lupus Erythematosus (ICCLE) 2013Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate AutoimmunitySerologic laboratory findings in malignancy.Antinuclear antibody prevalence in a general pediatric cohort from Mexico City: discordance between immunofluorescence and multiplex assays.COPD is associated with production of autoantibodies to a broad spectrum of self-antigens, correlative with disease phenotype.Presence of an interferon signature in individuals who are anti-nuclear antibody positive lacking a systemic autoimmune rheumatic disease diagnosis.Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification.Regulatory T cells in systemic lupus erythematosus and pregnancy.Breaching peripheral tolerance promotes the production of HIV-1-neutralizing antibodies.Immunological tolerance as a barrier to protective HIV humoral immunity.Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment.Prevalence of antinuclear antibodies in healthy Lebanese subjects, 2008-2015: a cross-sectional study involving 10,814 subjects.Editorial: Subduing Lupus: Can Preclinical Autoimmune Disease Be Arrested?Lack of Clinical Relevance of ANA and ASMA Positivity in Patients with Liver Transplantation without a History of Autoimmune DiseasesAntinuclear antibodies and mortality in the National Health and Nutrition Examination Survey (1999-2004).Antinuclear antibodies in healthy people: the tip of autoimmunity's iceberg?Gene expression patterns in livers of Hispanic patients infected with hepatitis C virus.Evaluation of anti-nuclear antibodies and kidney pathology in Lewis rats following exposure to Libby amphibole asbestos.[Early lupus erythematosus].Lupus after kidney donation to an affected male relative.Effects of Libby amphibole asbestos exposure on two models of arthritis in the Lewis rat.Association between antinuclear antibodies and the HLA class II locus and heterogeneous characteristics of staining patterns: the Nagahama study.Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?
P2860
Q26785472-4513880F-CD95-48A2-AFF7-331E7344935DQ26863306-5FE3370A-CBCB-4D0B-B3D8-2528D4BEFDE9Q31109622-F5AAC583-F74B-460A-8336-1EBF69B178D0Q33676588-3CB8EB38-E255-4BE1-95D3-0BBB4807A91AQ33771477-51AA0850-F3A4-479D-B2B2-A623B9C8F6A5Q34734509-C1485A8D-71D4-4380-AEAC-1B4370D913E7Q35007077-57DC2537-914A-4DA7-AF46-8CBFBDF95066Q35051889-EBDB7C47-D4E2-40EE-B1A3-1A7892BDBBF4Q35226822-033F2090-C386-482D-9B16-4A22AD70FCC2Q35632045-01AAA24C-7015-4FAB-B3F5-6E7C3ABF1BF6Q35731234-1E695E1C-9BB5-46EC-AA28-7FE24842FCEBQ36295504-1E6EA17F-21A5-4920-A994-EFE548BB081AQ36301524-4898E312-78BE-45E9-A857-CAA8A28732E2Q36477926-78955C47-BA4E-417C-A196-2C9439E4605BQ36633359-838AAD65-4853-4E5C-B791-DEAFE3686FCCQ36639920-EA8D31F5-4513-4A44-8742-0A14E12F1C9DQ36957998-8DCFBC0C-5637-4258-8049-38F324D9867EQ37038527-EF7E562B-38B3-4C05-B0DE-9727B8D214E6Q37297665-A05C7772-51F1-41DD-84A3-9800F672373FQ37401677-28F7EA6E-2674-40DF-B3B9-B9C1D27B0EB5Q37538473-73188002-5E2B-4FA8-BDA5-B863271B60EAQ37572312-799878D0-CB38-4623-B90E-3AA660ADCBF4Q37673362-3AE69C89-D2E3-4615-9AF0-C4C8082A7C61Q38016455-7F0E6FE1-C624-413F-A7BD-9FE10D83BE85Q38080562-A8ECB071-A97A-4450-A26E-499F2FF12372Q38683449-2323392E-7FCB-4F80-9F9C-5AC775869E83Q39447992-88EA516B-11D4-43FC-A55A-5FA360316E05Q40292542-EEABC182-2EF7-41B4-9CAE-0E61F228145BQ40644606-4B284ED8-1DB0-43C1-80C8-DEA686B84387Q41633161-E4AC1F17-8F13-4E9C-9182-AE2A4174AEFCQ42316456-CD4FBD0D-F62A-4521-A9D4-9484014B1DB7Q42708363-E2B6B631-B49E-404C-AC77-0957531E4F32Q42790883-1E0B53F1-70DF-4DBA-A9D5-A7E103366DB2Q43039948-9F870CE8-564D-4BB2-9756-4686A5BC7C66Q44269649-D0D20BA6-2D4C-43B0-B788-B8CA8DFB649DQ45081541-674041E0-06A1-4AB0-BABE-B36573E5D818Q46758237-1C43F6E0-3F65-4775-B42E-98EF985D915FQ47939010-B4E647C8-52BF-4F7F-A209-1833F2DF7896Q51115874-A13DA9A2-F711-4580-80CB-F4786FCE9B70Q52597638-4F1A30A6-7AE1-47C3-BE12-1DD86CDEB149
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Risk factors for ANA positivity in healthy persons
@ast
Risk factors for ANA positivity in healthy persons
@en
type
label
Risk factors for ANA positivity in healthy persons
@ast
Risk factors for ANA positivity in healthy persons
@en
prefLabel
Risk factors for ANA positivity in healthy persons
@ast
Risk factors for ANA positivity in healthy persons
@en
P2093
P2860
P356
P1476
Risk factors for ANA positivity in healthy persons
@en
P2093
Benjamin F Chong
David R Karp
Edward K Wakeland
Jiexia Quan
Jinchun Zhou
Nancy J Olsen
Quan-Zhen Li
Valerie K Branch
P2860
P2888
P356
10.1186/AR3271
P577
2011-03-02T00:00:00Z